HK1252779A1 - 抗真菌的4-(4-(4-(((3r,5r)-5-((1h-1,2,4-三唑-1-基)甲基)-5-(2,4-二氟苯基)四氫呋喃-3-基)甲氧基)-3-甲基苯基)哌嗪-1-基)-n-(2-羥基環己基)苯甲酰胺或其可藥用鹽 - Google Patents

抗真菌的4-(4-(4-(((3r,5r)-5-((1h-1,2,4-三唑-1-基)甲基)-5-(2,4-二氟苯基)四氫呋喃-3-基)甲氧基)-3-甲基苯基)哌嗪-1-基)-n-(2-羥基環己基)苯甲酰胺或其可藥用鹽

Info

Publication number
HK1252779A1
HK1252779A1 HK18112141.3A HK18112141A HK1252779A1 HK 1252779 A1 HK1252779 A1 HK 1252779A1 HK 18112141 A HK18112141 A HK 18112141A HK 1252779 A1 HK1252779 A1 HK 1252779A1
Authority
HK
Hong Kong
Prior art keywords
roxycyc
nzam
exyl
piperazin
difluorophenyl
Prior art date
Application number
HK18112141.3A
Other languages
English (en)
Inventor
Thomas Christopher Colley
Kazuhiro Ito
Peter Strong
Mihiro Sunose
Matthew Mcconville
Original Assignee
Pulmocide Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pulmocide Ltd filed Critical Pulmocide Ltd
Publication of HK1252779A1 publication Critical patent/HK1252779A1/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41961,2,4-Triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK18112141.3A 2015-05-21 2018-09-20 抗真菌的4-(4-(4-(((3r,5r)-5-((1h-1,2,4-三唑-1-基)甲基)-5-(2,4-二氟苯基)四氫呋喃-3-基)甲氧基)-3-甲基苯基)哌嗪-1-基)-n-(2-羥基環己基)苯甲酰胺或其可藥用鹽 HK1252779A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP15168637 2015-05-21

Publications (1)

Publication Number Publication Date
HK1252779A1 true HK1252779A1 (zh) 2019-05-31

Family

ID=53267232

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18112141.3A HK1252779A1 (zh) 2015-05-21 2018-09-20 抗真菌的4-(4-(4-(((3r,5r)-5-((1h-1,2,4-三唑-1-基)甲基)-5-(2,4-二氟苯基)四氫呋喃-3-基)甲氧基)-3-甲基苯基)哌嗪-1-基)-n-(2-羥基環己基)苯甲酰胺或其可藥用鹽

Country Status (17)

Country Link
US (3) US9969720B2 (zh)
EP (1) EP3298006B1 (zh)
JP (1) JP6811727B2 (zh)
KR (1) KR102653821B1 (zh)
CN (1) CN107635988B (zh)
AU (1) AU2016263669B2 (zh)
CA (1) CA2981945C (zh)
DK (1) DK3298006T3 (zh)
EA (1) EA032454B1 (zh)
ES (1) ES2790723T3 (zh)
HK (1) HK1252779A1 (zh)
HU (1) HUE048843T2 (zh)
IL (1) IL254943B (zh)
MX (1) MX2017014814A (zh)
NZ (1) NZ735783A (zh)
SG (1) SG11201708007VA (zh)
WO (1) WO2016185225A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2017014814A (es) * 2015-05-21 2018-02-15 Pulmocide Ltd 4-(4-(4-(((3r,5r)-5-((1h-1,2,4-triazol-1-il)metil)-5-(2,4-difluor ofenil)tetrahidrofuran-3-il)metoxi)-3-metilfenil)piperazin-1-il)- n-(2-hidroxiciclohexil) benzamida antifungica, o una sal farmaceuticamente aceptable de la misma.
CN109329288A (zh) * 2018-11-09 2019-02-15 青岛农业大学 伏立康唑在制备用于防治植物病原菌的杀菌剂中的应用
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1292472C (en) 1985-12-03 1991-11-26 Alfonsus Guilielmus Knaeps Derivatives of ¬¬4-¬4-(4-phenyl-1-piperazinyl)- phenoxymethyl|-1,3-dioxolan-2-yl|methyl|-1h-imidazoles and 1h-1,2,4-triazoles
JPH0717634B2 (ja) 1987-11-20 1995-03-01 シェリング・コーポレーション トリ‐およびテトラ‐置換‐オキセタンおよびテトラヒドロフランおよびその中間体
US5039676A (en) * 1990-05-11 1991-08-13 Schering Corporation Tri- and tetra-substituted-oxetanes and tetrahydrofurans and intermediates thereof
US5714490A (en) 1993-12-21 1998-02-03 Schering Corporation Tetrahydrofuran antifungals
ATE204875T1 (de) * 1993-12-21 2001-09-15 Schering Corp Fungizide tetrahydrofurane
US5486625A (en) 1994-07-08 1996-01-23 Schering Corporation Process for the preparation of chiral intermediates useful for the synthesis of antifungal agents
SK27097A3 (en) 1995-06-02 1997-09-10 Schering Corp Tetrahydrofuran antifungals
EP0957101A1 (en) * 1998-05-14 1999-11-17 Janssen Pharmaceutica N.V. Water soluble azoles as broad-spectrum antifungals
AU2002257104B2 (en) 2001-04-03 2006-02-09 Merck Sharp & Dohme Corp. Antifungal composition with enhanced bioavailability
EP1870405A1 (en) * 2006-06-22 2007-12-26 Bioprojet Carbonylated (Aza)cyclohexanes as dopamine D3 receptor ligands
CN101402613B (zh) * 2008-11-14 2013-07-24 中国人民解放军第二军医大学 取代酚氧烷基胺三唑醇类抗真菌化合物及其制备方法
CN102234267A (zh) * 2010-04-21 2011-11-09 中国科学院上海药物研究所 新型三氮唑类抗真菌化合物、其药物组合物及其制备方法和用途
US9346791B2 (en) * 2011-09-07 2016-05-24 The Johns Hopkins University Itraconazole analogs and use thereof
DK3227277T3 (da) 2014-12-05 2020-04-27 Pulmocide Ltd Antimykotisk forbindelse
MX2017014814A (es) * 2015-05-21 2018-02-15 Pulmocide Ltd 4-(4-(4-(((3r,5r)-5-((1h-1,2,4-triazol-1-il)metil)-5-(2,4-difluor ofenil)tetrahidrofuran-3-il)metoxi)-3-metilfenil)piperazin-1-il)- n-(2-hidroxiciclohexil) benzamida antifungica, o una sal farmaceuticamente aceptable de la misma.

Also Published As

Publication number Publication date
US20180251453A1 (en) 2018-09-06
KR20180010189A (ko) 2018-01-30
EP3298006A1 (en) 2018-03-28
ES2790723T3 (es) 2020-10-29
BR112017020807A2 (pt) 2018-07-03
JP6811727B2 (ja) 2021-01-20
US9969720B2 (en) 2018-05-15
US10280155B2 (en) 2019-05-07
US20170114047A1 (en) 2017-04-27
EP3298006B1 (en) 2020-01-01
CN107635988B (zh) 2021-06-18
WO2016185225A1 (en) 2016-11-24
CA2981945A1 (en) 2016-11-24
NZ735783A (en) 2021-12-24
CN107635988A (zh) 2018-01-26
EA032454B1 (ru) 2019-05-31
US10513511B2 (en) 2019-12-24
AU2016263669A1 (en) 2017-10-12
DK3298006T3 (da) 2020-03-30
AU2016263669B2 (en) 2020-04-30
IL254943A0 (en) 2017-12-31
US20190202813A1 (en) 2019-07-04
HUE048843T2 (hu) 2020-08-28
IL254943B (en) 2021-01-31
CA2981945C (en) 2023-08-29
MX2017014814A (es) 2018-02-15
EA201792558A1 (ru) 2018-05-31
KR102653821B1 (ko) 2024-04-02
JP2018520104A (ja) 2018-07-26
SG11201708007VA (en) 2017-12-28

Similar Documents

Publication Publication Date Title
IL259118A (en) Substituted oxadiazoles for combating phytopathogenic fungi
ZA201801534B (en) New uses of 2-(2,4-dichlorophenyl)methyl-4,4-dimethyl-3-isoxazolidone as foliar herbicide
PL3529246T3 (pl) Oksadiazole o działaniu grzybobójczym
GB201615051D0 (en) Multi-modal medical image procesing
IL247833A0 (en) 2-(2,4-difluorophenyl)-1,1-difluoro-1-(5-converted-pyridin-2-yl)-3-(1h-tetrazol-1-yl)propan-2-ols and processes for their preparation
IL247832A0 (en) 2-(2,4-difluorophenyl)-1,1-difluoro-1-(5-converted-pyridin-2-yl)-3-(1h-tetrazol-1-yl)propan-2-ols and processes for their preparation
IL260908B (en) Substituted 2-(het)aryl-imidazolyl-carboxyamides as pest control agents
HK1252779A1 (zh) 抗真菌的4-(4-(4-(((3r,5r)-5-((1h-1,2,4-三唑-1-基)甲基)-5-(2,4-二氟苯基)四氫呋喃-3-基)甲氧基)-3-甲基苯基)哌嗪-1-基)-n-(2-羥基環己基)苯甲酰胺或其可藥用鹽
ZA202103457B (en) Pesticidal compounds
IL275484A (en) W/O/W microemulsions for ophthalmic administration
IL260403B (en) Formulations of 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide
ZA201807105B (en) Treatment of a hematologic malignancy with 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide
DK3395342T3 (da) Tablet omfattende 1-(3-(2-(1-benzothiophen-5-YL)ethoxy)propyl)azetidin-3-ol eller salt deraf
EP3630964A4 (en) THERAPEUTIC AGENTS FOR GLYCOGEN STORAGE DISEASE TYPE III
HUE060120T2 (hu) Herbicidként aktív 4-difluormetilbenzoilamid
EP3426260A4 (en) FOR THE TREATMENT OF DISEASES USEFUL C-GLYCOSIDE COMPOUNDS
ZA201804843B (en) Salt forms and polymorphs of (r)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl) acetamido) pyridazin-3-yl)-2-fluorobutyl)-n-methyl-1h-1,2,3-triazole-4-carboxamide
IL271399A (en) Methods for the preparation of heterocyclic 3,1-benzodioxole compounds
HUE045226T2 (hu) Herbicid hatású N-(1,3,4-oxadiazol-2-il)arilkarboxamid-származékok
EP3534879A4 (en) FOAM FOR PULMONARY DRUG ADMINISTRATION
IL243650A0 (en) History of 1-(piperazine-1-yl)-2-([4,2,1]triazol-1-yl)-ethanone
EP3541797A4 (en) 4 - ((6- (2- (2,4-DIFLUORPHENYL) -1,1-DIFLUOR-2-HYDROXY-3- (5-MERCAPTO-1H
IL265893A (en) Crystal forms of 4-(2-((r1(2r,-2-hydroxycyclohexylamino)benzothiazol-6-yloxy)-n-methylpicolinamide
MA43157A (fr) Sels de 1-(4-(2-((1-(3,4-difluorophényl)-1h-pyrazol-3-yl)méthoxy)éthyl) pipérazin-1-yl)éthanone
IT201900000597U1 (it) Tavola fermapiede per ponteggi.